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Abstract
Techniques such as the real-time reverse transcription-polymerase chain reaction (qRT-PCR) can 
detect RNA in samples with a low viral load. However, these amplicons typically are either too 
short or at insufficient concentrations for use in subsequent sequencing reactions for genotyping 
and detection confirmation. The assay developed in this study detects rotavirus G genotypes and P 
genotypes with viral loads as low as 6.2 and 8.2 copies per reaction, respectively. The assay was 
validated using a panel of 91 stool samples, 32 reference rotavirus strains, and 6 non-target enteric 
virus samples.
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1. Introduction
Group A rotaviruses (RVA) are estimated to cause 453,000 deaths among infants and young 
children each year (Tate et al., 2012). The genome of RVA, members of the Reoviridae 
family, consists of 11 double-stranded RNA (dsRNA) segments that encode six viral 
structural proteins (VP1-VP4, VP6 and VP7) and five or six nonstructural proteins (NSP1-
NSP5/6) (Estes and Kapikian, 2007). Traditionally, viral classification was based on the 
serological characteristics and sequence diversity of the outer capsid proteins, VP7 
(glycosylated, G-type) and VP4 (protease-sensitive, P-type) (Iturriza-Gomara et al., 2004). 
Although, at least 32G genotypes and 46P genotypes have been identified to date (http://
rega.kuleuven.be/cev/viralmetagenomics/virus-classification) (Matthijnssens et al., 2011), 5 
strains (G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]) are associated with 80–90% of the 
global RVA disease burden (Patel et al., 2011).
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Numerous techniques are available for detection of RVA in stool samples, including virus 
isolation in cell culture, electron microscopy (EM), enzyme immunoassays (EIA), coupled 
reverse transcription and PCR amplification (RT-PCR), and real-time reverse transcriptase-
polymerase chain reactions (qRT-PCR) (Mijatovic-Rustempasic et al., 2013). Molecular 
techniques are more rapid and sensitive than cell culture-based techniques or EM. For 
example, reverse transcription-polymerase chain reaction (RT-PCR) assays targeting the 
RVA VP4, VP6 and VP7 gene segments have shown increases of 15–27% in the rate of RVA 
detection in comparison with EIA assays (Gouvea et al., 1991; Pang et al., 1999; Wilde et 
al., 1992; Xu et al., 1990). However, these approaches are not as sensitive as qRT-PCR. 
Recently, we described a one-step quantitative, highly sensitive and specific qRT-PCR assay 
targeting the NSP3 gene which can detect one genome copy per reaction (Mijatovic-
Rustempasic et al., 2013). Using this assay, we were able to detect 17% and 10% more RVA 
positives as compared to a commercially available EIA assay and hemi-nested RT-PCR, 
respectively (Das et al., 1994; Gentsch et al., 1992; Gouvea et al., 1990). However, a 
majority of RVA samples detected only with qRT-PCR had a Ct value greater than 30, 
indicating that the viral load in the sample was less than 100 copies per qRT-PCR assay. In 
addition, the qRT-PCR amplicon is 87 bp in length, too small to use for sequencing and not 
useful as a genotyping tool since it is amplified from the NSP3 (segment 7) gene. In this 
study, we developed nested primers that target the VP7 and VP4 genes of RVA in order to 
genotype by sequencing stool samples with low concentrations of RVA (100 copies per qRT-
PCR assay or qRT-PCR Ct ≥ 30). The advantage of the nested assay is that it permits G and 
P typing of samples with low copy numbers that are detected with qRT-PCR at concentration 
too low for direct sequencing.
2. Materials and methods
The nucleotide sequences of VP7 (G genotypes G1-G27) and VP4 (P genotypes P[1]-P[35]) 
gene segments available in Gen-Bank were aligned using GeneDoc version 2.7.000 
(Nicholas and Nicholas, 1997) and Multalign (Corpet, 1988). Multiple consensus and 
internal primer sets were designed manually and degenerate bases were introduced into the 
primer sequences to account for sequence variation observed in the sequence alignments of 
the genes mentioned above. The primer sequences were checked for specificity using 
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). All primers were checked for self-
annealing sites, hairpin loop formation, 3′ complementarity and melting temperatures (Tm) 
using the IDT oligonucleotide calculator (http://www.idtdna.com/analyzer/Applications/
OligoAnalyzer/). All the primers were synthesized by the Biotechnology Core Facility at the 
Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Stool samples (n = 91) from surveillance studies and outbreak investigations in the USA and 
international surveillance studies (Cardemil et al., 2012; Cortes et al., 2012; Gentsch et al., 
2009; Hull et al., 2011) were tested in this study. All samples were de-identified and could 
not be traced back to patient or hospital case identifiers. All specimens were collected 
between 2008 and 2014. Out of 91 samples, 64 (non-typeable samples with approximately 
100 copies per qRT-PCR assay or qRT-PCR Ct ≥ 30) and 27 samples (previously genotyped 
samples with more than 100 copies per qRT-PCR assay or qRT-PCR Ct ≤ 30) were used to 
assess sensitivity and specificity of the assay, respectively. Samples shown in Table 1 were 
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previously analysed by EIA (Premier™ Rotaclone® Rotavirus Detection Kit, Meridian 
Diagnostics, Inc., Cincinnati OH), hemi-nested RT-PCR (Hull et al., 2011), and qRT-PCR 
targeting the NSP3 gene (Mijatovic-Rustempasic et al., 2013). Of the 64 samples that were 
positive by qRT-PCR, all were negative by EIA and 60 were negative by RT-PCR. A 
majority of the samples (50 out of 64 samples) had fewer than 10 copies of the NSP3 gene 
per qRT-PCR reaction. Four samples tested by RT-PCR and qRT-PCR were positive with the 
VP7 assay, but were negative with the VP4 assay (samples 3, 8, 55 and 56, Table 1). Ten 
percent suspensions of each sample were prepared in PBS (10% PBS suspension) and RNA 
was extracted using the automated KingFisher extraction system (Thermo Electron 
Corporation, Vantaa, Finland) in accordance with the manufacturers’ instructions using 
program AM1836 with a volume input of 50 μL 10% PBS suspension and volume output of 
75 μL RNA in elution buffer. An additional 27 samples (Table 2), previously genotyped, had 
more than 100 copies of the NSP3 gene per qRT-PCR reaction and were used to check 
specificity of the assay. Samples were chosen based on their genotype to include the major 
circulating genotypes, G1-4, G9, G12, P[4], P[6] and P[8].
Thirty two reference RVA strains, previously propagated in MA104 cells, were extracted by 
the same protocol used for the stool samples except that undiluted stocks were used. The 
strains used were: Wa (G1P[8]), DS-1 (G2P[4]), ST3 (G4P[6]), P (G3P[8]), US1205 
(G9P[6]), 1076 (G2P[6]), 116E (G9P[11]), 69M (G8P[10]), AU-1 (G3P[9]), B223 
(G10P[11]), CC425 (G3P[9]), F123 (G14P[12]), HOCHI (G4P[8]), K8 (G1P[9]), L26 
(G12P[4]), NCDV (G6P[1]), OSU (G5P[7]), Ro1845 (G3P[3]), S2 (G2P[4]), Se584 
(G4P[9]), WI61 (G9P[8]), WC3 (G6P[5]), 157C (G3P[11]), F45 (G9P[8]), KU (G1P[8]), 
VA70 (G4P[8]), EDIM (G16P[16]), L338 (G13P[18]), SA-11 (G3P[1]), B37(G8P[X]), 
LAMB (G10P[15]), and UK (G6P[5]). RNA extracts were stored at −80 °C until testing.
The first round of the nested RT-PCR assay was performed using the Qiagen One-Step RT-
PCR Kit (Qiagen, Inc. Valencia, CA). Each 30 μL reaction mixture contained 15 μL of 
RNase-Free Water, 6 μL of 5× QIAGEN OneStep RT-PCR Buffer, 300 μM dNTP Mix, 2U 
QIA-GEN OneStep RT-PCR Enzyme Mix, 1 μM each forward and reverse primer and 4 μL 
of RNA extract. For the reaction targeting VP7, the forward primer, N-VP7F1, 5′-TAG CTC 
CTT TTR ATG TAT GGT A-3′, and the reverse primer, N-VP7R1, 5′-GTN GGC CAT CCT 
TTN GT-3′, were used to amplify a 333 bp amplicon (spanning nucleotides 37–370). For the 
VP4 reaction, the forward primer, N-VP4F1, 5′-GGC TAT AAA ATG GYT TCN YT-3′, 
and the reverse primer, N-VP4R1, 5′-ARY ADC CAR TAA TCR NYD RGT G-3′, were 
used to amplify a 257 bp amplicon (spanning nucleotides 1–257). After denaturing the RVA 
dsRNA and oligonucleotides for 5 min at 97 °C, the reaction mixture was added and reverse-
transcription and amplification were carried out on a GeneAMP PCR System 9700 
thermocycler (Applied Biosystems, Foster City, CA, USA). Thermocycling conditions 
consisted of a 30 min hold at 50 °C for reverse transcription, 15 min at 95 °C, and 35 cycles 
of 30 s at 95 °C, 30 s at 50 °C and 45 s at 72 °C, with a final hold of 7 min at 72 °C.
The second round of the nested RT-PCR assay was performed using the AmpliTaq® DNA 
Polymerase with Buffer II (Applied Biosystems, Foster City, CA, USA). Each 50 μL 
reaction mixture contained 26.5 μL Nuclease-Free Water (Ambion®, Austin TX), 5 μL of 
10X PCR Buffer II, 2 mM MgCl2 Solution, 8 μL 10 mM GeneAmp® dNTP Blend (Applied 
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Biosystems, Foster City, CA, USA), 2.5 U Ampli-Taq DNA Polymerase, 800 nM each 
forward and reverse primer and 2 μL of the 1st round RT-PCR reaction. For the reaction 
targeting the VP7 forward primer, N-VP7F2, 5′-ATG TAT GGT ATT GAA TAT ACC 
AC-3′, and the reverse primer, N-VP7R2, 5′-GTR TCC ATD GAT CCA GTN ATT GG-3′, 
were used to amplify a 193 bp amplicon (spanning nucleotides 49–242). For the VP4 
reaction forward primer, N-VP4F2, 5′-ATG GYT TCN YTM ATT TAT AGA CA-3′, and 
reverse primer, N-VP4R2, 5′-GNT GGY TGA TAW GGA CCR TCK A-3′, were used to 
amplify a 214 bp amplicon (spanning nucleotides 10–224). Thermocycling conditions 
consisted of 30 cycles of 45 s at 94 °C, 30 s at 42 °C and 60 s at 72 °C, with a final hold of 7 
min at 72 °C.
Second round amplicons were analyzed by gel electrophoresis using 3% agarose gels made 
of 1% low-melting-temperature NuSieve® GTG® Agarose (Lonza Inc., Rockland, ME) and 
2% SeaKem® ME Agarose (Lonza Inc., Rockland, ME) or 3% SeaKem® ME Agarose gels. 
The VP7 amplicons were subsequently excised and purified with a QIAquick Gel Extraction 
kit (Qiagen, Inc., Valencia, CA) following the manufacturer’s instructions. A majority of the 
VP4 amplicons produced single light bands on the gel. Therefore, the PCR products were 
purified using ExoSAP-IT® for PCR Product Clean-Up (Affymetrix, Santa Clara, CA) 
following the manufacturer’s protocol. DNA cycle sequencing was accomplished utilizing a 
Big Dye Terminator Cycle Sequencing kit v3.1 (Applied Biosystems, Inc., Foster City, CA) 
with individual PCR primers used for generating the second round product. Cycle sequenced 
products were purified using an in-house magnetic bead technique (Mijatovic-Rustempasic 
et al., 2012) and were analyzed on an ABI Prism 3130XL automated sequencer (Applied 
Biosystems, Foster City, CA, USA). Overlapping sequence fragments were assembled and 
edited in Sequencher 4.8 (Gene Codes Corporation, Inc., Ann Arbor, MI). The genotype for 
each amplicon was determined using BLAST to search the GenBank sequence database for 
highly similar matches to reference RVA strains.
Two positive control RNA templates were generated from the RVA VP4 and VP7 genes of 
laboratory strain Wa (G1P[8]) RNA, using a protocol described previously (Mijatovic-
Rustempasic et al., 2013). Additionally, G2, G3 and G9 transcripts were generated using the 
same protocol. The 10-fold serial dilutions of dsRNA transcripts were prepared in Nuclease-
Free Water (Ambion®, Austin TX) containing 100 μg/mL of carrier yeast RNA (Bio-Rad 
laboratories, Hercules CA). Positive controls were analysed on a LabChip GX Separation 
System using a DNA 1 K Reagent kit (Caliper Life Sciences-Perkin Elmer, Waltham, MA).
A second set of primers for amplification of VP7 was designed to address the observation 
that the quantity of the second round VP7 product was not dependent on the concentration of 
the positive control input when the Wa positive dsRNA RNA transcript is used: first round, 
N-VP7F537, 5′-GAR INC AAY TTR TGG ATI KCN ATG GG-3′ and N-VP7F903, 5′-
TCN CAN AYN GTR TAR AAN ACT TGC CAC CA-3′; and second round, N-VP7F481, 
5′-AYG AGT GGY TNT GYA AYC CIA TGG A-3′ and N-VP7R794, 5′-CCN CCI ATY 
TGI ATI AYN GCN ACY TT-3′. The same protocol described for RT-PCR and nested PCR 
of the VP7 gene was then used to amplify the VP7 positive control.
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The limit of detection (LOD) is the lowest quantity of an analyte that can be distinguished 
from the absence of that analyte (IUPAC, 1997). In order to establish the LOD of the new 
assay, 10-fold serial dilutions of the G1 and P[8] dsRNA transcripts were prepared and used 
as standard controls in assay runs. The concentrations of undiluted (devoid of carrier yeast 
RNA) G1 and P[8] transcripts were determined using the Nanodrop ND-1000 to be 352.6 
ng/μL and 1028.0 ng/μL, respectively. Eleven 10-fold serial dilutions (10−3–10−14), 
corresponding to copy numbers of 6.2 × 108 to 0 for the G1 transcript and 8.2 × 108 to 0 for 
the P[8] transcript, were tested using the assay conditions as described above. The LODs for 
VP7 and VP4 transcripts were calculated to be 6.2 and 8.2 copies per reaction, respectively, 
as shown in Fig. 1. For VP7, we observed both the first round RT-PCR and second round 
nested PCR products when we used a transcript to amplify the VP7 gene. This necessitated 
separation of products by gel electrophoresis followed by purification of templates from gel 
slices for sequencing both the first and second round PCR products (Fig. 1). We observed a 
single band for amplification of VP4 after two rounds of amplification. This product was a 
second round PCR amplicon which we were able to sequence by purifying the PCR product 
directly without gel separation. The size of the second round PCR amplicon for VP4 is 
linearly dependent on the concentration of the P[8] transcript, however a similar pattern was 
not observed for the VP7 amplicon when G1, G2, G3 or G9 transcript are used. To address 
this observation, additional primers were designed to amplify VP7 in a different area of the 
gene. A similar pattern of 2nd round amplification was observed for this set of primers as 
well, where the size of the second round amplicon was not linearly dependent on the sample 
input.
A total of 91 stool samples were extracted and analysed using the VP4 and VP7 nested 
PCRs (Tables 1 and 2). Out of 64 samples with a low viral load, we were able to detect and 
sequence VP4 and VP7 for 59 and 55 stool samples, respectively (Table 1). RVA strains 
represented in the stool samples tested included monotypic genotypes G1P[8], G2P[8], 
G3P[8], G9P[8], G3P[6], G1P[4], G2P[4] and G8P[4]. Three samples did not yield 
amplicons for both the VP4 and VP7 nested PCRs after the second PCR round. NSP3 copy 
numbers for these three stool samples were ≤1, 2.3, and 6.7 copies per qRT-PCR reaction. 
No evidence of PCR inhibition was found in these 3 samples by attempted amplification of 
diluted RNA. Increases of 85% and 92% in detection rates were recorded for nested VP7 
and VP4 PCRs when compared to previously described hemi-nested VP7 and VP4 RT-PCR 
assays, respectively (Table 1). One discrepancy was found when comparing nested assay 
results to the previously determined genotype for sample 56 (Table 1).
An additional 27 samples, which were genotyped previously, were used to confirm the 
specificity of the assay. Genotyping results obtained with the nested assay described in this 
report matched the genotyping results obtained previously by genotyping or sequencing in 
previous studies (Table 2).
The nested RT-PCR assay was able to detect all 32 reference RVA strains (data not shown). 
When nucleic acid extracts for non-RVA gastroenteritis viruses (Norovirus types GI and GII, 
Sapovirus types GI.2 and GIV, Astrovirus types 3, 7 and 8, Adenovirus types 40 and 41) 
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were tested with our assay, no amplicon was generated for any of the non-target viruses 
tested (data not shown).
4. Discussion
We developed and validated a highly sensitive nested RT-PCR assay for detecting RVA in 
stool samples with low viral load that targets all G and P genotypes. RVA can be shed at very 
high concentrations, up to approximately 1011 particles per g of stool (Flewett, 1983); 
therefore, samples are typically easy to genotype or sequence. However samples with low 
viral load, such as those collected during mild, asymptomatic, or late stage infections, are 
more difficult to genotype. Recently, we described a qRT-PCR assay targeting the NSP3 
gene that can detect one genome copy per reaction (Mijatovic-Rustempasic et al., 2013), 
allowing us to identify 10% more RVA positives as compared to hemi-nested RT-PCR assays 
that target the most common genotypes (Das et al., 1994; Gentsch et al., 1992; Gouvea et al., 
1990). However, a majority of RV samples detected only with qRT-PCR had viral loads of 
less than 100 copies per qRT-PCR assay and could not be sequenced directly or genotyped. 
This assay will permit typing of these low viral load samples.
The nested PCR reaction requires two set of primers that are used in two successive PCR 
reactions. The first amplicon is produced by an RT-PCR reaction using one set of primers 
while the second amplicon is produced by a PCR reaction using a second set of primers that 
bind inside the first amplicon. Nested RT-PCR has the advantage of improved sensitivity and 
specificity over conventional RT-PCR. Specificity improves because two sets of primers are 
used for nested RT-PCR reactions. Sensitivity increases because two rounds of PCR are 
performed. Nested PCR gained popularity in the early 1990s after Nichol and colleagues 
used nested PCR reactions to identify a novel hantavirus during an outbreak of a highly 
pathogenic acute respiratory illness (Nichol et al., 1993). Nested PCR reactions have been 
employed to detect a number of viruses (Aghasadeghi et al., 2013; Lam et al., 2007; Song et 
al., 2009), but not yet for RVA until this study.
Previously published hemi-nested RT-PCR assays targeted common RVA genotypes (Das et 
al., 1994; DiStefano et al., 2005; Gentsch et al., 1992; Gouvea et al., 1990; Iturriza-Gomara 
et al., 1999, 2000, 2004; Simmonds et al., 2008). The assay of Gouvea et al., a hemi-nested 
assay, targets VP7 genotypes G1-4, G8 and G9 by using genotype-specific primers along 
with a 3′ end consensus primer (Gouvea et al., 1990). Similarly, Gentsch et al. focused on 
the detection of common P-types such as P[4], P[6], P[8], P[9] and P[10] (Gentsch et al., 
1992). The assay’s limit of detection was determined by amplifying 10-fold serial dilutions 
of the four cultured stains and was found to be 104–105 virus particles. Later, a revised 
version of the assay targeting P[8] was published (Iturriza-Gomara et al., 2000). Das et al. 
developed a hemi-nested assay targeting the VP7 gene for amplification of G1-4 and G9 
genotypes (Das et al., 1994). Other hemi-nested primers targeting outer capsid genes follow 
a similar pattern of amplification with genotype specific primers while employing random 
primers from the RT step (Iturriza-Gomara et al., 1999). This assay can detect 10 virus 
particles/mL of 10% faecal suspension based on comparison of the 10-fold serial dilutions of 
cDNA generated with random primers and amplicons generated with consensus-specfic 
primers. As RVA evolves, primers used in these assays are constantly updated (Iturriza-
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Gomara et al., 2000; Iturriza-Gomara et al., 2004; Simmonds et al., 2008). There are other 
RT-PCR assays which employ sequencing in order to determine genotypes (DiStefano et al., 
2005; Simmonds et al., 2008), but none are in a nested PCR format.
The VP7 gene has 6 antigenic regions that are highly conserved among strains of the same 
genotype, but highly diverse between genotypes (Gouvea et al., 1990). The nested VP7 
primers developed in this study were designed to contain as many variable regions as 
possible to clearly distinguish between the genotypes. Sequences ranging obtained from the 
second round VP7 amplicon (excluding primer sequences) contain complete antigenic 
regions B and C and partial antigenic region D. The assay described in this report was 
designed and validated to detect and genotype broad range of RVA genotypes by subsequent 
sequencing.
The nested VP7 PCR developed in this study for both 1st round (RT-PCR) and 2nd round 
(nested PCR) is sensitive, (a LOD of 62.4 and 6.2 copies per reaction, respectively) and both 
products could be sequenced if gel purified. For the second round VP4 assay, only the 2nd 
round product is observed almost exclusively. We hypothesize that this is a result of the 
greater efficiency of the first round for the VP7 RT-PCR (62.4 copies per reaction) compared 
to the first round for the VP4 RT-PCR (8.2 × 105 copies per reaction; Fig. 1). Both nested 
PCRs, however, have comparable limits of detection (less than 10 copies per reaction).
A limitation of this study is that a small number of genotypes for stool samples with low 
viral load were tested due to limited availability of low viral load samples. However, 
previously genotyped strains with higher viral load, as well as reference strains tested in this 
study have provided a large diversity of genotypes tested. Including stool samples and 
reference strains, we have successfully amplified 27 genotypes, which include G1, G2, G3, 
G4, G5, G6, G8, G9, G10, G12, G13, G14, G16, P[1], P[3], P[4], P[5], P[6], P[7], P[8], 
P[9], P[10], P[11], P[12], P[15], P[16] and P[18].
In conclusion, a highly sensitive and highly specific nested RT-PCR assay targeting a large 
range of VP4 and VP7 genotypes, which can detect low viral load samples, has been 
developed and validated for the detection and genotyping of RVA. This is the first nested RT-
PCR that targets all RVA genotypes and the first RT-PCR method targeting RVA that uses a 
double-stranded transcript to determine the true LOD of the assay.
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Nested amplification of 10-fold serial dilutions of the G1 and P[8] dsRNA positive control 
transcript with VP7 and VP4 1st and 2nd round primers. Lanes: molecular weight marker 
(lane 1), 10−3–10−14 transcript dilutions (lanes 2–13) as indicated on the upper part of the 
lane. Numbers on the lower part of each lane (scientific notation) indicate copies per qRT-
PCR reaction. Amplicon sizes for first and second round VP7 amplification are 333 bp and 
193 bp and for VP4 amplification, 257 bp and 214 bp, respectively. 1st and 2nd round 
reactions were visualized using a LabChip® GX instrument (PerkinElmer, Inc., Waltham, 
MA).
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